Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations

Table 5

Retreatment between Days 56–90 in clinical Study 7 (Safety Population).

	1500 mg IV iron ()	1000 mg IV iron ()	value
(%) patients retreated	71 (5.6%)	142 (11.1%)

Data on file, Luitpold Pharmaceuticals, Inc.